AGP Executive Report
Last update: 5 hours agoWeight-loss ad lawsuit: Novo Nordisk is suing Eli Lilly over “false and materially misleading” weight-loss and diabetes ads, accusing Lilly of using outdated study comparisons and burying key context. Policy & access: Spain’s Council of Ministers approved a draft Medicines and Health Products law that changes how medicines are financed and aims to reduce supply shortages. Counterfeit/food safety: The U.S. FDA and CDC are tracking a cyclospora outbreak tied to shredded iceberg lettuce from Taylor Farms, after a prior positive test was later deemed a false alarm; Michigan reports thousands of cases. Clinical trial progress: Envoy Medical says all 56 patients hit the three-month milestone in its pivotal Acclaim cochlear implant trial as it works toward an FDA PMA submission. Healthcare business moves: Fresenius Medical Care launched TherapyWise Analytics to help clinicians optimize kidney replacement therapy using cloud-based insights. Community health: Azerbaijan repatriated 16 people from Syria and provided initial medical and psychosocial support. Care delivery expansion: CVS will now dispense select pet prescriptions at thousands of stores. Global health workforce: BRICS nations agreed to create a working group on traditional, complementary and integrative medicine.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
